 |
 |
 |
| 24小時(shí)熱門(mén)版塊排行榜 |
- >論壇更新日志 (6265)
- >導(dǎo)師招生 (1364)
- >考研 (1257)
- >蟲(chóng)友互識(shí) (822)
- >文獻(xiàn)求助 (394)
- >考博 (249)
- >休閑灌水 (195)
- >碩博家園 (146)
- >基金申請(qǐng) (88)
- >論文投稿 (71)
- >公派出國(guó) (67)
- >論文道賀祈福 (63)
- >招聘信息布告欄 (60)
- >教師之家 (57)
- >博后之家 (54)
- >SciFinder/Reaxys (39)
 |
 |
 |
||
 |
 |
 |
 |
 |
| 1 | 1/1 | 返回列表 |
| 查看: 392 | 回復(fù): 0 | |||
ining木蟲(chóng) (正式寫(xiě)手)
|
[交流]
3-13歲變應(yīng)性鼻炎患兒舌下特異性免疫治療的療效和安全性評(píng)估
|
|
Background: Sublingual immunotherapy (SLIT) is recommended for allergic diseases. However, clinical studies containing evidence-based data of thistreatment in young children, which is rarely reported in the literature, are needed. This study was designed to assess the efficacy and safety of SLIT in children,including very young children. Methods: Two hundred sixty-four children aged 3–13 years old (133 children, 3–5 years old) with Dermatophagoides farinae–induced allergic rhinitiswith or without asthma treated by standard harmacotherapy had randomly received either SLIT (SLIT group) or no SLIT (control group) for 12 months. Symptoms, medications, visual analog scale (VAS) and presence of adverse events (AEs) were assessed at monthly visits. Skin-prick test and Dermatophagoides farinae-specific IgE and IgG4 were easured before and after treatment. Results: Both treatments were effective in the global clinical scores during the first seven visits when compared with baseline (all, p 0.01), and SLIT showed lower symptoms scores and VAS scores throughout this period (all, p 0.01). These improvements continued until the later visits only in the SLIT group. Also, the asthma medication consumption was decreased by SLIT treatment only at the end of study (p 0.01). The specific IgG4 was significantly increased after SLIT treatment when compared with the control group, but no significant change of specific IgE was observed in either groups. In the SLIT group, there was no significant difference between children less than or more than 5 years old in terms of clinical efficacy, onset of action, immunologic parameters, and safety. No severe systemic AEs were reported. Conclusion: SLIT is effective and well-tolerated in children with allergic rhinitis 3-13 years old. |
回復(fù)此樓» 猜你喜歡
國(guó)自然等
已經(jīng)有12人回復(fù)
-
中醫(yī)藥研究生出國(guó)交流學(xué)習(xí)找學(xué)校老師
已經(jīng)有0人回復(fù)
-
消化系統(tǒng)論文潤(rùn)色/翻譯怎么收費(fèi)?
已經(jīng)有90人回復(fù)
-
求治白癜風(fēng)方法
已經(jīng)有4人回復(fù)
-
有人中過(guò)博士后優(yōu)秀學(xué)術(shù)著作出版基金嗎？
已經(jīng)有0人回復(fù)
-
2025博士申請(qǐng)考核求定位
已經(jīng)有2人回復(fù)
-
中西醫(yī)結(jié)合專(zhuān)碩，309分求調(diào)劑
已經(jīng)有5人回復(fù)
-
中西醫(yī)結(jié)合專(zhuān)碩309分，求調(diào)劑
已經(jīng)有0人回復(fù)
-
求臨床醫(yī)學(xué)專(zhuān)碩調(diào)劑，或者學(xué)碩！
已經(jīng)有0人回復(fù)
-
中醫(yī)302分，求調(diào)劑
已經(jīng)有0人回復(fù)
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 ining 的主題更新
| 1 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 0856化工原理 +5 | z2839474511 2026-03-10 | 5/250 |
|
|---|---|---|---|---|
|
|
[考博] 售SCI一區(qū)T0P文章，我:8.O.5.5.1.O.5.4,科目齊全,可+急 +3 | 7x4iz20zqa 2026-03-11 | 8/400 |
|
|
[考研] 311求調(diào)劑 +6 | zchqwer 2026-03-10 | 6/300 |
|
|
|
[考研] 083000環(huán)境科學(xué)與工程調(diào)劑 +8 | mingmingry 2026-03-09 | 9/450 |
|
|
|
[考研] 304求調(diào)劑（085602一志愿985） +8 | 化工人999 2026-03-09 | 8/400 |
|
|
|
[考研] 327分求調(diào)劑086 +4 | 西紅柿?小帥 2026-03-09 | 7/350 |
|
|
|
[考研] 材料與化工，291，求調(diào)劑 +12 | 咕嚕咕嚕123123 2026-03-05 | 13/650 |
|
|
|
[考研] 085701環(huán)境工程295求調(diào)劑，一志愿A區(qū)211 +8 | 等春來(lái)， 2026-03-06 | 9/450 |
|
|
|
[考研] 294 英二數(shù)二物化 求調(diào)劑 +6 | 米飯團(tuán)不好吃 2026-03-09 | 6/300 |
|
|
|
[考研]
 295復(fù)試調(diào)劑
+4
|
簡(jiǎn)木ChuFront 2026-03-09 | 4/200 |
|
|
|
[考研] 0703求調(diào)劑 +10 | c297914 2026-03-06 | 11/550 |
|
|
|
[考研] 320求調(diào)劑 +4 | 魏zy 2026-03-08 | 4/200 |
|
|
|
[考研] 0856求調(diào)劑 +3 | squirtle11 2026-03-07 | 3/150 |
|
|
|
[考博] 26年博士申請(qǐng) +4 | 科研狗111 2026-03-07 | 4/200 |
|
|
|
[考研] 286求調(diào)劑 +12 | Faune 2026-03-06 | 14/700 |
|
|
|
[考研] 303求調(diào)劑 +8 | forgman95 2026-03-05 | 10/500 |
|
|
|
[考研] 材料調(diào)劑 +7 | ounce. 2026-03-05 | 15/750 |
|
|
|
[考研] 085701環(huán)境工程317分求調(diào)劑 +9 | 6汆尼9 2026-03-07 | 9/450 |
|
|
|
[考研] 322分 085600求調(diào)劑，有互聯(lián)網(wǎng)+國(guó)金及主持省級(jí)大創(chuàng)經(jīng)歷 +4 | 熊境喆 2026-03-05 | 4/200 |
|
|
|
[考研] 276求調(diào)劑 本科天津工業(yè)大學(xué) 一志愿北京化工大學(xué)0855 +4 | 路lyh123 2026-03-06 | 6/300 |
|